271 related articles for article (PubMed ID: 28721479)
1. New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?
Holtz JN; Silverman RK; Tay KJ; Browning JT; Huang J; Polascik TJ; Gupta RT
Abdom Radiol (NY); 2018 Mar; 43(3):702-712. PubMed ID: 28721479
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
4. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
[TBL] [Abstract][Full Text] [Related]
5. Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.
Velez E; Fedorov A; Tuncali K; Olubiyi O; Allard CB; Kibel AS; Tempany CM
Abdom Radiol (NY); 2017 Aug; 42(8):2154-2159. PubMed ID: 28293720
[TBL] [Abstract][Full Text] [Related]
6. COMPARISON OF GRADING ACCURACY OF PROSTATE CANCER IN SAMPLES ACQUIRED BY A TARGETED AND SYSTEMIC PROSTATE BIOPSY.
Pezelj I; Pirša M; Svaguša I; Nikles S; Tomić M; Knežević M; Tomašković I; Krušlin B
Acta Clin Croat; 2022 Oct; 61(Suppl 3):28-31. PubMed ID: 36938557
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.
Muller BG; Kaushal A; Sankineni S; Lita E; Hoang AN; George AK; Rais-Bahrami S; Kruecker J; Yan P; Xu S; de la Rosette JJ; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Urol Oncol; 2015 Oct; 33(10):425.e1-425.e6. PubMed ID: 26259666
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
[TBL] [Abstract][Full Text] [Related]
9. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
10. Prediction of unilateral prostate cancer by the combination of transrectal ultrasonography-guided prostate biopsy and multi-parametric magnetic resonance imaging: A real-life experience.
Kim JJ; Kim T; Lee H; Byun SS; Lee SE; Choe G; Hong SK
PLoS One; 2018; 13(8):e0202872. PubMed ID: 30157232
[TBL] [Abstract][Full Text] [Related]
11. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
[TBL] [Abstract][Full Text] [Related]
12. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
13. Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy.
Lu AJ; Syed JS; Nguyen KA; Nawaf CB; Rosoff J; Spektor M; Levi A; Humphrey PA; Weinreb JC; Schulam PG; Sprenkle PC
Urology; 2017 Jul; 105():118-122. PubMed ID: 28322902
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.
Panebianco V; Valerio MC; Giuliani A; Pecoraro M; Ceravolo I; Barchetti G; Catalano C; Padhani AR
Eur Urol Oncol; 2018 Aug; 1(3):208-214. PubMed ID: 31102623
[TBL] [Abstract][Full Text] [Related]
16. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
19. A negative multiparametric magnetic resonance imaging finding does not guarantee the absence of significant cancer among biopsy-proven prostate cancer patients: a real-life clinical experience.
Kim JJ; Byun SS; Lee SE; Lee HJ; Choe G; Hong SK
Int Urol Nephrol; 2018 Nov; 50(11):1989-1997. PubMed ID: 30229465
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of multiparametric magnetic resonance imaging to detect significant prostate cancer and index lesion location.
Goldman H; Singh N; Harding C; McGirr J; Seal A; Duncan I; Sowter S
ANZ J Surg; 2019 Jan; 89(1-2):106-110. PubMed ID: 30257273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
